Low UVA doses activate the transcription factor NFAT in human fibroblasts by a calcium–calcineurin pathway

• Published in: Free radical biology & medicine Vol. 39; no. 12; pp. 1629 - 1637
• Main Authors: Mazière, Cécile, Morlière, Patrice, Louandre, Christophe, Conte, Marie-Alix, Gomilla, Cathy, Santus, René, Antonicelli, Franck, Hornebeck, William, Mazière, Jean-Claude
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.12.2005; Elsevier
• Subjects: Antioxidants - pharmacology; Calcineurin; Calcineurin - metabolism; Calcineurin Inhibitors; Calcium; Calcium - metabolism; Cell Survival - drug effects; Cell Survival - radiation effects; Cells, Cultured; Cyclosporine - pharmacology; DNA - metabolism; DNA - radiation effects; Dose-Response Relationship, Radiation; Egtazic Acid - analogs & derivatives; Egtazic Acid - pharmacology; Fibroblasts - metabolism; Fibroblasts - radiation effects; Free radicals; Humans; NFATC Transcription Factors - drug effects; NFATC Transcription Factors - metabolism; Nuclear factor of activated T cells; Protein Binding - drug effects; Protein Binding - physiology; Protein Binding - radiation effects; Signal Transduction - physiology; Signal Transduction - radiation effects; Tacrolimus - pharmacology; Ultraviolet Rays; UVA; Vitamin E - pharmacology; UVA; Free radicals; Calcium; Calcineurin; Nuclear factor of activated T cells
• ISSN: 0891-5849; 1873-4596
• DOI: 10.1016/j.freeradbiomed.2005.08.003

UVA radiation induces an inflammatory response as observed in erythema, and the cytokine genes involved in this response are under the control of the transcription factor NFAT (nuclear factor of activated T lymphocytes). The effects of UVA on NFAT DNA binding activity were investigated in cultured human fibroblasts. A dose-dependent increase was observed within the range of 0.6–4.5 J/cm 2 UVA. Beyond this value, the activity decreased and a value of 60% of control was found at 13.5 J/cm 2. The enhancement of NFAT activity was transient and peaked 45 min after irradiation. Furthermore, immunoblot analysis demonstrated a nuclear translocation of NFAT under low UVA doses. Concomitantly, as assessed by the fluorescent probe Fluo3, UVA induced an increase in intracellular free calcium, with a maximum increase found at 9 J/cm 2. The UVA-induced activation of NFAT was prevented by the intracellular calcium trapping drug BAPTA, whereas the extracellular calcium chelator EGTA had no significant effect. In addition, the calcineurin inhibitors cyclosporin A and FK506 both prevented the UVA-induced NFAT activation. Furthermore, the antioxidant vitamin E prevented the UVA-induced increase in both intracellular free calcium and NFAT binding activity. Finally, the cytotoxicity of UVA was enhanced in the presence of the inhibitors cyclosporin and FK506, suggesting that the activation of NFAT might play a protective role after the UVA-induced oxidative stress. These results demonstrate that UVA activates the calcium–calcineurin signaling pathway of NFAT activation, that the calcium ions are mainly released from intracellular stores, and that the increase in calcium is, at least partially, due to the oxidative stress generated under UVA. Because NFAT regulates several genes implicated in the inflammatory response, the enhancement of NFAT activity by low UVA doses might be interpreted in view of the proinflammatory action of solar radiation.